Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinoma.
Gramantieri L, Suzzi F, Bassi C, D'Abundo L, Tovoli F, Bruccoleri M, Marseglia M, Alimenti E, Fornari F, Negrini M, Iavarone M, Piscaglia F, Giovannini C.
Gramantieri L, et al. Among authors: giovannini c.
Eur J Immunol. 2024 Feb;54(2):e2350637. doi: 10.1002/eji.202350637. Epub 2023 Dec 8.
Eur J Immunol. 2024.
PMID: 37990855